A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 138,755 shares of NBIX stock, worth $17.4 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
138,755
Holding current value
$17.4 Million
% of portfolio
0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $15.9 Million - $21.3 Million
138,755 New
138,755 $16 Million
Q2 2023

Aug 04, 2023

BUY
$89.53 - $104.87 $449,619 - $526,657
5,022 Added 3.76%
138,755 $13.1 Million
Q4 2021

Feb 15, 2022

BUY
$79.65 - $106.22 $10.7 Million - $14.2 Million
133,733 New
133,733 $11.3 Million
Q3 2020

Nov 12, 2020

SELL
$96.16 - $135.15 $480,800 - $675,750
-5,000 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$75.11 - $113.76 $375,550 - $568,800
5,000 New
5,000 $432,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.